Biohit Oyj

Report Publication Announcement • Mar 27, 2020

Publication of Biohit Oyj Annual Report 2019 and Renumeration Policy 2020

Publication of Biohit Oyj Annual Report 2019 and Renumeration Policy 2020

Biohit Oyj Annual Financial Report and Renumeration Policy

Biohit Oyj’s Annual Report 2019 is published today in PDF format. The annual
report contains financial statements for 2019, the Report of the Board of
Directors and Corporate Governance Statements.Annual report is published in
Finnish and English, and it can be read and downloaded from Biohit company
website:

https://www.biohithealthcare.com/en/investors/annual-reports/

Biohit has also published the Remuneration Policy for the Governing Bodies,
which will be presented in the Annual General Meeting 2020. The Policy sets the
principles for the remuneration of the company’s governing bodies. The policy is
available at https://www.biohithealthcare.com/en/investors/.

Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com (https://www.globenewswire.com/Tracker?data=F7USWVHKzHva
X-wfSDZQcANme4hiXnyDOMsYd7_hh0-v5DJ8cXf2bZjeB
-DIAzDZFpopELnpgMmEnA_kpyYmLGTqvkGETAk2QfpwclEc6SE=)

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and services
to promote research and early diagnosis. Biohit is headquartered in Helsinki,
Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share
(BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com (https://www.globenewswire.com/Tracker?data=F7USWVHKzHva
X-wfSDZQcANme4hiXnyDOMsYd7_hh0-HphCZT
-UWUifHMeiFjvXkBDZQ62S4EwZW_vCTZLKUtXA4wJQzLvKWLu5SyZMTKVM=)

Attachments: